The complaint evaluation for a false elevated afp result included a search for similar complaints, and review of complaint text, trending data, labelling, and device history records review.Return testing was not completed as returns were not available.Performance of complaint reagent lot was evaluated using world wide data.The patient data was analyzed and compared to an established control limit.This evaluation indicated that the patient median result for complaint lot is within the established control limits, therefore, no unusual reagent lot performance was identified.Lot and trending review did not identify an increase in complaint activity for the lot for the issue and no related trend for the issue for the product.Device history record review on complaint lot did not show any potential non-conformances, or deviations.Labelling was reviewed and found to adequately address the issue under review.Based on the evaluation, no systemic issue or product deficiency of the architect afp assay was identified.
|